GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy
GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy
Enrolling by invitation · NCT06772402 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Atrophy, Spinal, Type II, Spinal Muscular Atrophies of Childhood, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy | Enrolling by invitation | Not applicable | 2026-09-11 | NCT06772402 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Genecombio Ltd. | 2 |
| The Children's Hospital of Zhejiang University School of Medicine | 74 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital ZheJiang Univisity School Of Medicine | Hangzhou | China | 1 |